"Two months later, we will set up the biggest production base of flu vaccine (in north China) in Tianjin", the principal of Tianjin Tasly Jinna Biotechnology Co., Ltd. announced recently. The base should supply flu vaccine to north China even to whole country, and can relieve the pressure accaused by the demand for flu vaccine rises sharply.
It was said that now the best measure for prevention of flu is the inoculation of flu vaccine. Now besides foreign enterprises such as GSK, the main manufactures are several biology institutions affiliated to China National Biotec. Group. The shortage of flu vaccine is big.
The production base will produce flu subunit vaccine. Flu subunit vaccine owns best safety and highest content of effective antigen, but it's hard to produce. The company spent 6 years on the research, and the third generation subunit vaccine shoud be marketed. It's expected the new vaccine should be marketed in three years.